Quick Takeaways
- Carl Goldfischer has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $10,645,656.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Carl Goldfischer
- Location
- New York, NY
- Summary
- The estimated net worth of Carl Goldfischer is at least $10,645,656 dollars as of 20 Jun 2025. Carl Goldfischer is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $10.65M.
- Signature
- /s/ Hans T. Schambye, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Carl Goldfischer and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: IMARA Inc. ($10,645,656).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Carl Goldfischer
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ELVN | IMARA Inc. | Director | $10,645,656 | 02 Jun 2022 | ||
| EPZM | Epizyme, Inc. | Director | 12 Aug 2022 | |||
| DMRA | Galecto, Inc. | Director | 18 Jun 2025 |
Insider Transactions Reported by Carl Goldfischer:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.